Pfizer to Fund Study of Celebrex as Heart Aid -WSJ
481067
Pharmaceutical giant Pfizer Inc. will announce plans for a large-scale clinical trial of the ability of blockbuster drug Celebrex to prevent heart attacks and strokes in patients with cardiovascular disease, the Wall Street Journal reported on Monday.
497581
U.S. drug reviewers have questioned Pfizer Inc.'s  data showing the pain reliever Celebrex was as effective as an older drug in treating juvenile rheumatoid arthritis, according to documents released on Tuesday.
445972
Pfizer Inc. has agreed to license a  set of potential drugs for the prevention of stroke and heart  attacks from Germany's Schering, the two companies said on  Wednesday.
659779
GAITHERSBURG, Maryland  - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children, a U.S. advisory panel said in a 15-1 vote on Wednesday despite concerns about the drug's long-term safety.
72495
PFIZER, the drugs group best known for producing Viagra, has suffered a collapse in US sales of its blockbuster Celebrex painkiller on the back of clinical trials showing a heightened risk of heart attacks.
649232
Just weeks after Merck &amp; Co. pulled its anti-inflammatory drug Vioxx from the market, rival Celebrex, marketed by Pfizer Inc. , is mounting a wide-scale, consumer-oriented ad campaign to get people to ask their doctors about the drug.
391949
U.S. drug reviewers have questioned Pfizer Inc.'s  data showing the pain reliever Celebrex was as effective as an older drug in treating juvenile rheumatoid arthritis, a summary released on Tuesday said.
698387
FRIDAY, Dec. 17 (HealthDayNews) -- Pfizer Inc. said Friday that a study of its popular pain drug Celebrex in cancer patients had found an apparent increased risk of heart attack and other cardiovascular problems.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
483616
Pfizer Inc. may fall short in convincing federal regulators that its painkiller Celebrex should receive expanded approval to treat children with a devastating form of arthritis, according to documents released Tuesday.
326752
Pfizer plans to ask for approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
684774
Pfizer Inc.'s pain  reliever Celebrex should be approved for treating rheumatoid  arthritis in children despite uncertainty about the risks of  long-term use, U.S. advisers said on Wednesday.
41856
Pfizer Inc.âs disclosure of a study linking Celebrex to heart attacks, such as Merck &amp; Co.âs withdrawn Vioxx, means demand for the drugs once known as âsuper aspirin
626406
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, the Wall Street Journal said.
493704
Pfizer is pulling its radio, TV, newspaper and magazine advertising for Celebrex in the wake of a study that links high doses of the popular arthritis to an increased risk of heart attack, but the company plans to keep Celebrex on the market.
390080
Pfizer acknowledged that a clinical trial found that elderly patients taking Celebrex were more likely to suffer heart problems than patients taking a placebo.
349840
Pfizer Inc. PFE.N is close to an  agreement to buy Angiosyn Inc., a biotech start-up working on a  drug to ward off blindness, in a deal potentially valued at  $527 million, the Wall Street Journal reported on Thursday,  citing people familiar with the situation.